Genomics and Epigenomics of the Elderly Response to Pneumococcal Vaccines

Trial Profile

Genomics and Epigenomics of the Elderly Response to Pneumococcal Vaccines

Recruiting
Phase of Trial: Phase II

Latest Information Update: 27 Apr 2017

At a glance

  • Drugs Pneumococcal 13-valent CRM197 vaccine conjugate (Primary) ; Pneumococcal vaccine (Primary)
  • Indications Pneumococcal infections
  • Focus Pharmacodynamics
  • Sponsors The Jackson Laboratory
  • Most Recent Events

    • 24 Apr 2017 Status changed from not yet recruiting to recruiting.
    • 11 Apr 2017 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top